HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

5th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 18-20 | Hybrid Event

September 18-20, 2025 | London, UK

Proteomics and Metabolomics

Proteomics and Metabolomics

Proteomics and metabolomics delve into the dynamic functional layers of biological systems, offering critical insights beyond genomic information. Proteomics focuses on large-scale analysis of protein expression, structure, interactions, and post-translational modifications, shedding light on cellular behavior and disease mechanisms. Metabolomics, on the other hand, profiles the complete set of small-molecule metabolites within a biological system, providing a snapshot of physiological states and metabolic changes in real time. These disciplines are instrumental in biomarker discovery, drug development, systems biology, and personalized medicine. Advanced tools such as mass spectrometry, NMR spectroscopy, and bioinformatics platforms are essential in navigating the complexity of biological networks. Proteomics and metabolomics collectively contribute to understanding disease progression, optimizing therapeutics, and predicting treatment outcomes with unparalleled precision.

Committee Members
Speaker at Biotechnology and Bioengineering 2025 - Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States
Speaker at Biotechnology and Bioengineering 2025 - Steve Busby

Steve Busby

University of Birmingham, United Kingdom
Speaker at Biotechnology and Bioengineering 2025 - Murray Moo Young

Murray Moo Young

University of Waterloo, Canada
ECBB 2025 Speakers
Speaker at Biotechnology and Bioengineering 2025 - Julia Sidorova

Julia Sidorova

Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Speaker at Biotechnology and Bioengineering 2025 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Universidad Autonoma de Baja California, Mexico
Speaker at Biotechnology and Bioengineering 2025 - Assad Al Ammar

Assad Al Ammar

Specialty Enzymes and Probiotics, United States
Speaker at Biotechnology and Bioengineering 2025 - Tina Moller Tagmose

Tina Moller Tagmose

Novo Nordisk A/S, Denmark
Tags

Submit your abstract Today

Watsapp
a